Nicorette (Nicotine)

Nicotine, the active ingredient in Nicorette, is a nicotine replacement therapy presented as a transdermal patch for transdermal use. It helps adult smokers quit by reducing withdrawal symptoms and cravings, and it is classified under ATC code N07BA02 and available over‑the‑counter in the European Union.

GNH USA supplies Nicorette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nicorette is a nicotine replacement therapy used to support smoking cessation. - Smoking cessation: assists adult smokers in quitting by alleviating withdrawal symptoms and reducing cravings. - Tobacco dependence: provides a controlled nicotine dose to replace cigarettes and facilitate gradual reduction. - Relapse prevention: helps maintain abstinence by delivering steady nicotine levels during the critical post‑quit period.

Common Side Effects: - Skin irritation at the application site: redness, itching, or mild rash. - Sleep disturbance: difficulty falling asleep or staying asleep. - Vivid dreams: unusually intense or memorable dreams. - Nausea: mild upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Allergic reaction: swelling, hives, or difficulty breathing. - Severe skin reaction: blistering or severe dermatitis. - Chest pain: unexpected discomfort or pressure in the chest. - Hypertension: sudden increase in blood pressure.

Before using Nicorette, consider the following precautions: - Cardiovascular assessment: evaluate heart disease or hypertension status. - Medical guidance: use under the direction of a healthcare professional. - Non‑smokers: avoid use in individuals who do not currently smoke. - Concurrent nicotine products: do not combine with other nicotine‑containing therapies. - Child safety: keep patches out of reach of children and pets. - Store at room temperature: keep in the original packaging, protect from moisture and direct heat.

Nicorette may interact with other substances as follows: Major Interactions (Avoid): - Other nicotine products: risk of nicotine overdose and increased side effects. - Beta‑blockers: nicotine can diminish the blood‑pressure‑lowering effect of beta‑blockers. - Monoamine oxidase inhibitors (MAOIs): may exacerbate hypertension. Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., certain antiretrovirals): may raise nicotine plasma levels. - Antidepressants (especially SSRIs): may increase the likelihood of vivid dreams. - Alcohol: can intensify nicotine cravings and affect metabolism.